Alfa Cytology can detect specific sequence changes in DNA isolated from brain tumor patient samples (e.g., peripheral blood extracellular vesicles from glioma patients) to identify potential biological markers. RNAs (including miRNAs and lncRNAs) obtained from peripheral blood or body fluid exosomes are more abundant and tumor-specific. Therefore, we looked for proteins that were highly expressed by observing the expression profiles of exosomal miRNA and lncRNA in brain tumors (glioblastoma) compared with normal tissues as biological markers for the diagnosis of glioblastoma. Alfa Cytology provides services on exosome for brain tumors.
